“Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation”-Reference-Cited by-同舟云学术

“Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation”

Published:2023-03-23 Issue:6 Volume:58 Page:680-686
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Altareb Majed,Al-Awwami Moheeb,Alfraih Feras,Alhayli Saud,Ahmed Syed Osman,Shaheen Marwan,Chaudhri Naeem,Alsharif Fahad,Alkhabbaz Hana,Albabtain Abdulwahab A.,Alfayez Mansour,Hanbali Amr,Alshaibani Alfadel,Alotaibi Ahmad S.,Rasheed Walid,Algharably Amal,Almohareb Fahad,Alahmari Ali,Alzahrani Hazzaa,Aljurf Mahmoud^ORCID,El Fakih Riad^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01950-4.pdf

Reference36 articles.

1. Ciurea SO, Bayraktar UD. “No donor”? Consider a haploidentical transplant. Blood Rev. 2015;29:63–70.

2. El Fakih, R., Arat, M., Aljurf, M. Donor Selection and Cell Dose in Haploidentical SCT. In: Demirer, T. editor. Haploidentical Stem Cell Transplantation. Stem Cell Biology and Regenerative Medicine. Humana Press, Cham; 2017. https://doi.org/10.1007/978-3-319-65319-8_2.

3. El Fakih R, Lazarus HM, Muffly L, Altareb M, Aljurf M, Hashmi SK. Historical perspective and a glance into the antibody-based conditioning regimens: a new era in the horizon? Blood Rev. 2021;52:100892.

4. Picascia A, Grimaldi V, Napoli C. From HLA typing to anti-HLA antibody detection and beyond: The road ahead. Transplant Rev. 2016;30:187–94.

5. Ciurea SO, De Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem cell transplantation. Transplantation. 2009;88:1019.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies;Transplantation and Cellular Therapy;2024-09

2. The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center;Frontiers in Oncology;2024-08-21

3. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know;Oncology and Therapy;2024-06-15

4. Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation;BLOOD TRANSFUS-ITALY;2024

5. Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin;Transplantation and Cellular Therapy;2024-03